How to make a decision on the choice of therapy for multiple sclerosis with sarcoidosis comorbidity?

Neurosciences (Riyadh). 2022 Oct;27(4):279-281. doi: 10.17712/nsj.2022.4.20220024.

Authors

Svetlana D Miletic-Drakulic¹, Vladimir S Jankovic¹, Sandra M Radevic¹, Snezana R Lazarevic¹

Affiliation

¹ From the Department of Neurology, Faculty of Medical Sciences, University of Kragujevac, Serbia. Address correspondence and reprint request to: Dr. Snezana Lazarevic, Department of Neurology, Faculty of Medical Sciences, University of Kragujevac, Serbia. E-mail: simovicsnezana2@gmail.com Orcid ID: https://orcid.org/0000-0002-2052-4800.

No abstract available

MeSH terms

Comorbidity
Humans
Multiple Sclerosis* / complications
Multiple Sclerosis* / therapy
Sarcoidosis* / complications
Sarcoidosis* / therapy